An Autoantibody is Modified for Use as a Delivery System to Target the Cell Nucleus: Therapeutic Implications

A murine monoclonal anti-dsDNA antibody was found to penetrate living cells and localize in the nucleus without pathologic effects. A single mutation in VHmarkedly enhanced cellular penetration. The mutant antibody was produced as recombinant Fab and single chain antibody fragments to investigate it...

Full description

Saved in:
Bibliographic Details
Published inJournal of autoimmunity Vol. 11; no. 5; pp. 539 - 546
Main Authors Weisbart, Richard H., Stempniak, Mariusz, Harris, Scott, Zack, Debra Jeske, Ferreri, Kevin
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A murine monoclonal anti-dsDNA antibody was found to penetrate living cells and localize in the nucleus without pathologic effects. A single mutation in VHmarkedly enhanced cellular penetration. The mutant antibody was produced as recombinant Fab and single chain antibody fragments to investigate its use as a delivery system to target the cell nucleus. Complexes were made containing Fab fragments and alkaline phosphatase conjugated goat antibodies to mouse |gk chains. Fab fragments transported 305kDa goat antibody–enzyme complexes into the nucleus in COS-7 and CHO cells. A single chain antibody cDNA was constructed by splice overlap extension PCR and expressed in COS-7 cells. Binding of the single chain antibody to dsDNA was shown by ELISA, and cellular penetration and nuclear localization were demonstrated in COS-7 and CHO cells. The single chain antibody cDNA was ligated into the expression vector, pEGFP, to produce a fusion protein with green fluorescent protein. The fusion protein penetrated COS-7 cells and localized in the cell nucleus. The single chain antibody produced during sustained expression in CHO cells re-entered antibody-producing cells and localized in the nucleus without affecting cell viability. Our results demonstrate the potential use of a modified autoantibody as a delivery system to target the cell nucleus.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0896-8411
1095-9157
DOI:10.1006/jaut.1998.0212